ACTIVE

Beisol Pharma Kortenberg

Export PDF
Financial year 2025 · closed on 31/03/2025
Net result
18,3 k €
+189.3% YoY
Revenue
26,9 k €
-55.6% YoY
Equity
-68,8 k €
+21.0% YoY

What does Beisol Pharma Kortenberg do?

Beisol Pharma Kortenberg is a Private company with limited liability incorporated in 2014. Its main activity is: Leasing of intellectual property and similar products, except copyrighted works. Its registered office is in Lubbeek.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0544.650.050
Incorporation
22/01/2014
Legal form
Private company with limited liability
Registered office
Staatsbaan(LUB) 187
3210 Lubbeek · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
31/03/2025
Activities (NACE)
77400Leasing of intellectual property and similar products, except copyrighted works· main77400Leasing of intellectual property and similar products, except copyrighted works
Contacts
3 public details availableLog in to view
Signals
ProfitablePositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 11 financial years

20252024202320222021202020192018201720162015
Income statement
Revenue26,9 k €60,5 k €60,5 k €50,8 k €71 k €78,5 k €78,4 k €78,4 k €89,7 k €89,7 k €89,7 k €
EBITDA18,4 k €49,3 k €47,2 k €44,3 k €62,8 k €70,2 k €69 k €77,4 k €82,9 k €83,9 k €87,7 k €
Operating result18,4 k €-20,4 k €-22,5 k €-25,5 k €-7 k €516 €-1 k €7,4 k €12,9 k €13,9 k €17,7 k €
Net result18,3 k €-20,5 k €-26,3 k €-26,6 k €-11 k €-4,9 k €-8,5 k €-775 €3,1 k €1,8 k €231 €
Balance sheet
Equity-68,8 k €-87,1 k €-66,6 k €-40,3 k €-13,7 k €-2,7 k €2,2 k €10,6 k €11,4 k €8,3 k €6,4 k €
Total assets247,9 k €262,5 k €314,6 k €358,7 k €413,5 k €480,7 k €351,9 k €419,3 k €498,3 k €765,2 k €830,5 k €
Cash42 €9 €57 €–0 €231 €193 €683 €1,1 k €469 €879 €
Debts316,7 k €349,6 k €381,3 k €399,1 k €427,3 k €483,4 k €349,8 k €408,6 k €486,9 k €757 k €824,1 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 1 ended

Active mandates

Carine Knapen

Mandate

Active
Theo Schrevens

Mandate

Active

Ended mandates

Teofiel Schrevens

Mandate

Ended
At this address

Other companies at this address

CompanyCBE no.
Beisol Pharma Lubbeek● Active
0773.648.838
Beisol Pharma Meerle● Active
0544.650.644
Beisol Pharma Merkplas● Active
0544.652.723
Beisol Pharma Neerijse● Active
0544.653.020
Beisol Pharma Poederlee● Active
0544.651.040
Beisol Pharma Tienen● Active
0544.648.961
CRAYNWINKEL● Active
0474.769.468
KULAPRO● Active
0419.774.527
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelAbridged model
Start of the financial year01/04/202401/04/202301/04/202201/04/202101/04/202001/04/2019
Closing of the financial year31/03/202531/03/202431/03/202331/03/202231/03/202131/03/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date20/10/202515/10/202423/10/202317/10/202230/09/202115/11/2020
General meeting25/09/202519/09/202423/10/202313/09/202215/09/202117/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/03/202525/09/202520/10/2025DutchPDF
Micro model31/03/202419/09/202415/10/2024DutchPDF
Micro model31/03/202323/10/202323/10/2023DutchPDF
Micro model31/03/202213/09/202217/10/2022DutchPDF
Micro model31/03/202115/09/202130/09/2021DutchPDF
Abridged model31/03/202017/09/202015/11/2020DutchPDF
Abridged model31/03/201912/09/201908/10/2019DutchPDF
Abridged model31/03/201806/09/201806/09/2018DutchPDF
Abridged model31/03/201714/09/201706/11/2017DutchPDF
Abridged model31/03/201608/09/201613/09/2016DutchPDF
Abridged model31/03/201510/09/201514/09/2015DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 1 ended

Active mandates

Carine Knapen

Mandate

Active
Theo Schrevens

Mandate

Active

Ended mandates

Teofiel Schrevens

Mandate

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other24/01/2014
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202518,3 k €↑
  2. 2024
    Annual accounts 2024-20,5 k €↑
  3. 2023
    Annual accounts 2023-26,3 k €↑
  4. 2022
    Annual accounts 2022-26,6 k €↓
  5. 2021
    Annual accounts 2021-11 k €↓
  6. 2020
    Annual accounts 2020-4,9 k €↑
  7. 2019
    Annual accounts 2019-8,5 k €↓
  8. 2018
    Annual accounts 2018-775 €↓
  9. 2017
    Annual accounts 20173,1 k €↑
  10. 2016
    Annual accounts 20161,8 k €↑
  11. 2015
    Annual accounts 2015231 €
  12. 22/01/2014
    IncorporationPrivate company with limited liability